Health Care
(E12)
IRS Verified
DX Registered
990 on File
LITTLE HERCULES FOUNDATION
Financial strength (30%)
78/100
Reliability (20%)
50/100
Effectiveness (25%)
86/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
My youngest child was diagnosed with Duchenne muscular dystrophy ("DMD") when he was five years old. As a result, I founded the Little Hercules Foundation to fund research in the hopes of finding a cure and/or treatment for him and all boys with DMD. DMD is the leading genetic killer of children, and occurs in approximately 1 in 3,500 live male births. Boys start showing muscle weakness around the age of 3-6, and are normally in a wheelchair by the age of 10-12. This disease robs our boys of the ability to run, jump, climb, play sports, and eventually compromises heart and lung function. Most boys with DMD do not live past their early 20s. DMD IS 100% FATAL.
Financial Overview — FY 2024
$613K
Total Revenue
$621K
Total Expenses
$14K
Net Assets
5
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
75.5%
Fundraising Efficiency
N/A
Operating Reserve
0.28x
Liability-to-Asset
45.2%
Revenue Diversification
100.0%
Executive Compensation
$404K
Compared with Peers
FY 2024
Compared with 4,558 similar organizations
(United States, Health Care, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
75.5% | 84.8% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
20.1% | 10.9% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
4.4% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.3 mo | 13.1 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
45.2% | 1.3% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 93.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
22.0% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
5.5% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-1.3% | 3.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $613K | $621K | $14K | 75.5% | 5 |
| 2023 | $502K | $588K | $22K | 71.0% | 6 |
| 2022 | $517K | $574K | $108K | 73.1% | 5 |
| 2021 | $535K | $561K | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.